A centrifugal ultrafiltration strategy for isolating the low-molecular weight (≤ 25 K) component of human plasma proteome

Journal of Proteomics

Volumn 73, Issue 3, 2010, Pages 637-648

  Greening, David W ^a,b   Simpson, Richard J ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Blood; HUPO; Low molecular weight proteins; Peptidomics; Plasma; Proteomics; Ultrafiltration

Indexed keywords

BINDING PROTEIN; BLOOD CLOTTING FACTOR 13A; CLUSTERIN; COFILIN 1; FIBRINOGEN; INTER ALPHA TRYPSIN INHIBITOR; KINOGEN 1; MEMBRANE PROTEIN; PLASMA PROTEIN; PPIASE A; PROTEIN KIAA0649; PROTEOME; RHEUMATOID FACTOR; RHEUMATOID FACTOR D5; SERINE PROTEASE INHIBITOR A3; SERINE PROTEINASE INHIBITOR; SH3 DOMAIN BINDING GLUTAMIC ACID RICH LIKE PROTEIN 3; TRANSFERRIN; TRANSMEMBRANE ADAPTER PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; FILTER; HUMAN; LIQUID CHROMATOGRAPHY; MOLECULAR WEIGHT; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TANDEM MASS SPECTROMETRY; ULTRAFILTRATION;

BLOOD PROTEINS; CELL FRACTIONATION; CENTRIFUGATION; CLUSTER ANALYSIS; DATABASES, PROTEIN; HEMOFILTRATION; HUMANS; MICROPORE FILTERS; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; PROTEOME; PROTEOMICS; ULTRAFILTRATION;

EID: 72149117946     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.09.013     Document Type: Article

References (43)

1. Chen Y., Yu P., Luo J., and Jiang Y. Secreted protein prediction system combining CJ-SPHMM, TMHMM, and PSORT. Mamm Genome 14 12 (2003) 859-865
2. Lopez M.F., Mikulskis A., Kuzdzal S., Bennett D.A., Kelly J., Golenko E., et al. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clin Chem 51 10 (2005) 1946-1954
3. Liotta L.A., and Petricoin E.F. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest 116 1 (2006) 26-30
4. Drake R.R., Cazares L., and Semmes J.O. Mining the low molecular weight proteome of blood. Proteomics Clin Appl 1 (2007) 758-768
5. Jain R.K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6 4 (1987) 559-593
6. Dvorak H.F., Nagy J.A., Dvorak J.T., and Dvorak A.M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133 1 (1988) 95-109
7. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55 17 (1995) 3752-3756
8. Dellian M., Yuan F., Trubetskoy V.S., Torchilin V.P., and Jain R.K. Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer 82 9 (2000) 1513-1518
9. Shen Y., Kim J., Strittmatter E.F., Jacobs J.M., Camp II D.G., Fang R., et al. Characterization of the human blood plasma proteome. Proteomics 5 15 (2005) 4034-4045
10. Tang H.Y., Ali-Khan N., Echan L.A., Levenkova N., Rux J.J., and Speicher D.W. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 5 13 (2005) 3329-3342
11. Greenough C., Jenkins R.E., Kitteringham N.R., Pirmohamed M., Park B.K., and Pennington S.R. A method for the rapid depletion of albumin and immunoglobulin from human plasma. Proteomics 4 10 (2004) 3107-3111
12. Bjorhall K., Miliotis T., and Davidsson P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5 1 (2004) 307-317
13. States D.J., Omenn G.S., Blackwell T.W., Fermin D., Eng J., Speicher D.W., et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol 24 3 (2006) 333-338
14. Omenn G.S., States D.J., Adamski M., Blackwell T.W., Menon R., Hermjakob H., et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 13 (2005) 3226-3245
15. Zhou M., Lucas D.A., Chan K.C., Issaq H.J., Petricoin III E.F., Liotta L.A., et al. An investigation into the human serum "interactome". Electrophoresis 25 9 (2004) 1289-1298
16. Rothemund D.L., Locke V.L., Liew A., Thomas T.M., Wasinger V., and Rylatt D.B. Depletion of the highly abundant protein albumin from human plasma using the Gradiflow. Proteomics 3 3 (2003) 279-287
17. Pieper R., Su Q., Gatlin C.L., Huang S.T., Anderson N.L., and Steiner S. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3 4 (2003) 422-432
18. Gundry R.L., Fu Q., Jelinek C.A., Van Eyk J.E., and Cotter R.J. Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl 1 1 (2007) 73-88
19. Granger J., Siddiqui J., Copeland S., and Remick D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 5 18 (2005) 4713-4718
20. Lowenthal M.S., Mehta A.I., Frogale K., Bandle R.W., Araujo R.P., Hood B.L., et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 51 10 (2005) 1933-1945
21. Tirumalai R.S., Chan K.C., Prieto D.A., Issaq H.J., Conrads T.P., and Veenstra T.D. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2 10 (2003) 1096-1103
22. Harper R.G., Workman S.R., Schuetzner S., Timperman A.T., and Sutton J.N. Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry. Electrophoresis 25 (2004) 1299-1306
23. Zheng X., Baker H., and Hancock W.S. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 1120 1-2 (2006) 173-184
24. Hu L., Li X., Jiang X., Zhou H., Jiang X., Kong L., et al. Comprehensive peptidome analysis of mouse livers by size exclusion chromatography prefractionation and nanoLC-MS/MS identification. J Proteome Res 6 2 (2007) 801-808
25. Luque-Garcia J.L., and Neubert T.A. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. J Chromatogr A 1153 1-2 (2007) 259-276
26. Jung W.W., Phark S., Oh S., Khim J.Y., Lee J., Nam M.H., et al. Analysis of low molecular weight plasma proteins using ultrafiltration and large gel two-dimensional electrophoresis. Proteomics 9 7 (2009) 1827-1840
27. Georgiou H.M., Rice G.E., and Baker M.S. Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins. Proteomics 1 12 (2001) 1503-1506
28. Greening D.W., Glenister K., Sparrow R., and Simpson R.J. Enrichment of human platelet membrane-cytoskeletal proteins for proteomic analysis. In: Pierce M. (Ed). Proteomic analysis of membrane proteins: methods and protocols. Methods in Molecular Medicine Series (2009), Humana Press 245-258
29. Pieters M., Jerling J.C., and Weisel J.W. Effect of freeze-drying, freezing and frozen storage of blood plasma on fibrin network characteristics. Thromb Res 107 5 (2002) 263-269
30. Lewis M.R., Callas P.W., Jenny N.S., and Tracy R.P. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost 86 6 (2001) 1495-1500
31. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 1 (1985) 76-85
32. Olsen J.V., de Godoy L.M., Li G., Macek B., Mortensen P., Pesch R., et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4 12 (2005) 2010-2021
33. Perkins D.N., Pappin D.J., Creasy D.M., and Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 18 (1999) 3551-3567
34. Greening D.W., Glenister K.M., Kapp E.A., Moritz R.L., Sparrow R.L., Lynch G.W., et al. Comparison of human platelet-membrane cytoskeletal proteins with the plasma proteome: Towards understanding the platelet-plasma nexus. Proteomics Clin Appl 2 (2008) 63-77
35. Kapp E.A., Schutz F., Reid G.E., Eddes J.S., Moritz R.L., O'Hair R.A., et al. Mining a tandem mass spectrometry database to determine the trends and global factors influencing peptide fragmentation. Anal Chem 75 22 (2003) 6251-6264
36. Nielsen H., Engelbrecht J., Brunak S., and von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 10 1 (1997) 1-6
37. Harris M.A., Clark J., Ireland A., Lomax J., Ashburner M., Foulger R., et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32 (2004) D258-D261 (Database issue)
38. Apweiler R., Bairoch A., Wu C.H., Barker W.C., Boeckmann B., Ferro S., et al. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res 32 (2004) D115-D119 (Database issue)
39. Croda-Todd M.T., Soto-Montano X.J., Hernandez-Cancino P.A., and Juarez-Aguilar E. Adult cystatin C reference intervals determined by nephelometric immunoassay. Clin Biochem 40 13-14 (2007) 1084-1087
40. Schenk S., Schoenhals G.J., de Souza G., and Mann M. A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 1 (2008) 41
41. Villanueva J., Philip J., Entenberg D., Chaparro C.A., Tanwar M.K., Holland E.C., et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76 6 (2004) 1560-1570
42. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., et al. Dual regulation of snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6 10 (2004) 931-940
43. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116 1 (2006) 271-284